Unknown

Dataset Information

0

Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure.


ABSTRACT: The existence of radio- and chemotherapy-surviving cancer stem cells is currently believed to explain the inefficacy of anti-glioblastoma (GBM) therapies. The aim of this study was to determine if a therapeutic strategy specifically targeting GBM stem cells (GSC) would completely eradicate a GBM tumor. In both the in vitro and the in vivo models, ganciclovir therapy targeting proliferating GSC promotes the survival of a quiescent, stem-like cell pool capable of reproducing the tumor upon release of the therapeutic pressure. Images of small niches of therapy-surviving tumor cells show organized networks of vascular-like structures formed by tumor cells expressing CD133 or OCT4/SOX2. These results prompted the investigation of tumor cells differentiated to endothelial and pericytic lineages as a potential reservoir of tumor-initiating capacity. Isolated tumor cells with pericyte and endothelial cell lineage characteristics, grown under tumorsphere forming conditions and were able to reproduce tumors after implantation in mice.

SUBMITTER: Guerra-Rebollo M 

PROVIDER: S-EPMC6606606 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure.

Guerra-Rebollo Marta M   Garrido Cristina C   Sánchez-Cid Lourdes L   Soler-Botija Carolina C   Meca-Cortés Oscar O   Rubio Nuria N   Blanco Jerónimo J  

Scientific reports 20190702 1


The existence of radio- and chemotherapy-surviving cancer stem cells is currently believed to explain the inefficacy of anti-glioblastoma (GBM) therapies. The aim of this study was to determine if a therapeutic strategy specifically targeting GBM stem cells (GSC) would completely eradicate a GBM tumor. In both the in vitro and the in vivo models, ganciclovir therapy targeting proliferating GSC promotes the survival of a quiescent, stem-like cell pool capable of reproducing the tumor upon release  ...[more]

Similar Datasets

| S-EPMC4489496 | biostudies-literature
| S-EPMC3754928 | biostudies-literature
| S-ECPF-GEOD-24716 | biostudies-other
| S-EPMC6332999 | biostudies-literature
| S-EPMC3033231 | biostudies-literature
2010-10-16 | GSE24716 | GEO
| S-EPMC3382131 | biostudies-literature
| S-EPMC6759502 | biostudies-literature
| S-EPMC5648000 | biostudies-literature
| S-EPMC4725906 | biostudies-literature